Evidence map›Paper›PMID 39139355›Full record

ArticleHemaSphere2024

How to manage patients with germline

Panagiotis Baliakas, Bianca Tesi, Jörg Cammenga, Asbjørg Stray-Pedersen, Kirsi Jahnukainen, Mette Klarskov Andersen, Helena Ågerstam, Maria Creignou, Ingunn Dybedal, Klas Raaschou-Jensen and 4 more

Abstract read
In one paragraph

Article in HemaSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Germline DDX41 mutations in myeloid neoplasms: a comprehensive review.The Korean journal of internal medicine · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers.European journal of human genetics : EJHG · 2025
    Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Panagiotis BaliakasDepartment of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden.ORCID https://orcid.org/0000-0002-5634-7156
Bianca TesiDepartment of Molecular Medicine and Surgery and Centre of Molecular Medicine Karolinska Institutet Stockholm Sweden.ORCID 0000-0002-8253-2507
Jörg CammengaDepartment of Haematology, Oncology and Radiation Physics Skåne University Hospital Lund Sweden.ORCID https://orcid.org/0000-0001-5573-7542
Asbjørg Stray-PedersenHabilitation Unit, Sanderud Innlandet Hospital Trust Brumunddal Norway.ORCID 0000-0002-9168-0878
Kirsi JahnukainenApplied Tumor Genomics Research Program, Research Programs Unit, Faculty of Medicine University of Helsinki Helsinki Finland.ORCID https://orcid.org/0000-0001-9296-2028
Mette Klarskov AndersenDepartment of Clinical Genetics Rigshospitalet, Copenhagen University Hospital Copenhagen Denmark.ORCID https://orcid.org/0000-0003-2449-5565
Helena ÅgerstamDepartment of Laboratory Medicine, Division of Clinical Genetics Lund University Lund Sweden.ORCID https://orcid.org/0009-0002-8216-3876
Maria CreignouDepartment of Medicine Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet Stockholm Sweden.ORCID https://orcid.org/0000-0002-7629-0871
Ingunn DybedalDepartment of Hematology Oslo University Hospital, Rikshospitalet Oslo Norway.ORCID https://orcid.org/0000-0002-3229-3069
Klas Raaschou-JensenDepartment of Hematology Odense University Hospital Odense Denmark.ORCID https://orcid.org/0000-0002-4032-6617
Kirsten GrønbækDepartment of Hematology Rigshospitalet, Copenhagen University Hospital Copenhagen Denmark.ORCID https://orcid.org/0000-0002-1535-9601
Outi KilpivaaraApplied Tumor Genomics Research Program, Research Programs Unit, Faculty of Medicine University of Helsinki Helsinki Finland.ORCID https://orcid.org/0000-0001-8467-2100
Eva Hellström LindbergDepartment of Medicine Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet Stockholm Sweden.ORCID https://orcid.org/0000-0002-7839-3743
Ulla Wartiovaara-KauttoApplied Tumor Genomics Research Program, Research Programs Unit, Faculty of Medicine University of Helsinki Helsinki Finland.ORCID https://orcid.org/0000-0002-2803-2712

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing recognition of germline

Identifiers

PMID39139355
PMCPMC11320078

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.